Salud financiera de hoja de balance de Elevance Health
Salud financiera controles de criterios 4/6
Elevance Health tiene un patrimonio de accionistas total de $42.3B y una deuda total de $27.7B, lo que sitúa su ratio deuda-patrimonio en 65.5%. Sus activos y pasivos totales son $113.0B y $70.7B respectivamente. El BAIT de Elevance Health es de $10.5B, por lo que su ratio de cobertura de intereses es de 9.9. Tiene efectivo e inversiones a corto plazo que ascienden a $36.0B.
Información clave
65.5%
Ratio deuda-patrimonio
US$27.69b
Deuda
Ratio de cobertura de intereses | 9.9x |
Efectivo | US$35.99b |
Patrimonio | US$42.30b |
Total pasivo | US$70.69b |
Activos totales | US$112.99b |
Actualizaciones recientes sobre salud financiera
Is Elevance Health (NYSE:ELV) Using Too Much Debt?
Apr 16Is Elevance Health (NYSE:ELV) A Risky Investment?
Jan 02These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely
Oct 04Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly
Jul 05We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt
Apr 04Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly
Nov 28Recent updates
Investors Continue Waiting On Sidelines For Elevance Health, Inc. (NYSE:ELV)
Sep 11Elevance Health: Strong Earnings Growth Supports Strong Dividend Growth
Sep 06There's Been No Shortage Of Growth Recently For Elevance Health's (NYSE:ELV) Returns On Capital
Aug 29Here's Why We Think Elevance Health (NYSE:ELV) Is Well Worth Watching
Aug 02Elevance Health: Healthcare Services Segment Is Gaining Traction
Jul 31Elevance Health: Buy A Dividend Growth Machine
Jul 18Elevance Health: Favorable Trends Are Emerging (Rating Upgrade)
Jun 28Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?
Jun 11Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher
May 27We Think Shareholders Will Probably Be Generous With Elevance Health, Inc.'s (NYSE:ELV) CEO Compensation
May 09Elevance Health (NYSE:ELV) Has Announced A Dividend Of $1.63
Apr 25Elevance Health: It's Not Too Late To Buy Their Dividend Growth
Apr 23Is Elevance Health (NYSE:ELV) Using Too Much Debt?
Apr 16Elevance Health: Not Doing Enough In 2024 To Justify Premium Price
Apr 11Elevance Health, Inc.'s (NYSE:ELV) Earnings Haven't Escaped The Attention Of Investors
Apr 01Elevance: A Healthy Dose Of Dividend Growth
Mar 21Elevance Heath: Financial Growth And Technical Strength Indicate A Buy
Mar 07Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63
Feb 19Elevance Health: Time To Buy This Incredible Dividend Growth Stock
Jan 26Slowing Rates Of Return At Elevance Health (NYSE:ELV) Leave Little Room For Excitement
Jan 19Is Elevance Health (NYSE:ELV) A Risky Investment?
Jan 02Elevance Health, Inc.'s (NYSE:ELV) Shares Not Telling The Full Story
Dec 18A Look At Elevance's Margin Dynamics
Nov 23Is It Time To Consider Buying Elevance Health, Inc. (NYSE:ELV)?
Nov 16Elevance Health: A High Conviction Defensive Blue Chip Buy
Oct 19These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely
Oct 04Elevance: Pave The Way For The Next UnitedHealth
Sep 21Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital
Sep 18Here's The Price I Would Buy Elevance Health Stock
Sep 13If EPS Growth Is Important To You, Elevance Health (NYSE:ELV) Presents An Opportunity
Aug 18Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?
Aug 04Narrowing Down High-Quality Dividend Growth: Elevance Health Is Elemental
Jul 24Elevance Health: Beaten Down Share Price Offers Solid Potential
Jul 10Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly
Jul 05Elevance Health: A Critical Update (Rating Downgrade)
Jun 05Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher
Jun 04Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?
May 05We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt
Apr 04Elevance Health's (NYSE:ELV) Dividend Will Be Increased To $1.48
Feb 17Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital
Feb 13Elevance Health: Attractive On Its Expansion Catalysts
Feb 09Elevance Health (NYSE:ELV) Has Announced That It Will Be Increasing Its Dividend To $1.48
Jan 28Elevance Health acquiring Blue Cross and Blue Shield of Louisiana
Jan 23Elevance Health Offers Great Value
Jan 17At US$483, Is Elevance Health Inc. (NYSE:ELV) Worth Looking At Closely?
Jan 17Elevance Health: Strong And Steady EPS Growth Ahead, High Relative Strength Name
Jan 02Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly
Nov 28Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($62.3B) de ELV superan a sus pasivos a corto plazo ($41.8B).
Pasivo a largo plazo: Los activos a corto plazo de ELV ($62.3B) superan a sus pasivos a largo plazo ($28.9B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: ELV tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de ELV ha crecido de 64.5% a 65.5% en los últimos 5 años.
Cobertura de la deuda: La deuda de ELV no está bien cubierta por el flujo de caja operativo (13.5%).
Cobertura de intereses: Los pagos de intereses de la deuda de ELV están bien cubiertos por el BAIT (9.8x cobertura).